Live Breaking News & Updates on பெர்னாண்டோ கந்ஹ

Stay updated with breaking news from பெர்னாண்டோ கந்ஹ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer
AB2 BioDecember 16, 2020 GMT
Will drive commercial strategy and execution of Tadekinig alfa, currently in Phase 3
Joins AB2 Bio from Novartis and has extensive commercial and strategic experience
LAUSANNE, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) AB2 Bio Ltd., a Phase 3 clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, today announced the appointment of Djordje Filipovic, PhD, as Chief Commercial Officer (CCO).
Dr Filipovic has more than 20 years of experience as a pharmaceutical executive, covering functions in marketing, strategy, general management at local, regional and global levels as well as in research and development. In his role as CCO of AB2 Bio, Dr Filipovic will be a key member of the Executive Team, re ....

Michael Soldan , Djordje Filipovic , Marieke Vermeersch , Fernando Cunha , Ecole Polytechnique Fe , Hemophagocytic Lymphohistocytosis , Fbio Ltd , Swiss Federal Institute Of Technology , Chief Commercial Officer , Executive Team , Primary Hemophagocytic Lymphohistocytosis , Chief Executive Officer , Novartis Oncology Portfolio Management , Swiss Federal Institute , Drug Designation , Breakthrough Therapy , Pediatric Rare Disease Designations , Priority Review , Innovation Park , Sci Advisors , மைக்கேல் சொல்தான் , பெர்னாண்டோ கந்ஹ , உயிர் லிமிடெட் , சுவிஸ் கூட்டாட்சியின் நிறுவனம் ஆஃப் தொழில்நுட்பம் , தலைமை வணிகரீதியானது அதிகாரி , நிர்வாகி அணி ,